References
Van Praag, D., andSimon, E. J. 1966. Studies on the intracellular distribution and tissue binding of dihydromorphine-7,8-3H in the rat. Proc. Soc. Exp. Biol. Med. 122:6–11.
Goldstein, A., Lowney, K. I., andPal, B. K.1971. Stereospecific and nonspecific interactions of the morphine congener levorphanol in subcellular fractions of mouse brain. Proc. Natl. Acad. Sci. U. S. A. 68:1742–1747.
Simon, E. J., 1973. Opiate receptors. Presented at symposium on Current Status of Pharmacological Receptors, American Society of Pharmacology and Experimental Therapeutics, Atlantic City, New Jersey, April 18, 1973.
Simon, E. J., Hiller, J. M., andEdelman, I. 1973. Stereospecific binding of the potent narcotic analgesic3H-etorphine to rat brain homogenate. Proc. Natl. Acad. Sci. U.S.A. 70:1947–1949.
Terenius, L. 1973. Stereospecific interaction between narcotic analgesics and a synaptic plasma membrane fraction of rat cerebral cortex. Acta Pharmacol. Toxicol. 32:317–320.
Pert, C. B., andSnyder, S. H. 1973. Opiate receptor: Demonstration in nervous tissue. Science 179:1011–1014.
Pert, C. B., Snowman, A. M., andSnyder, S. H. 1974. Localization of opiate receptor binding in synaptic membranes of rat brain. Brain Res. 70:184–188.
Hitzeman, R. J., Hitzeman, B. A., andLoh, H. H. 1974. Binding of3H-naloxone in the mouse brain: Effect of ions and tolerance development. Life Sci. 14:2393–2404.
Hiller, J. M., Pearson, J., andSimon, E. J. 1973. Distribution of stereospecific binding of the potent narcotic analgesic etorphine in the human brain: Predominance in the limbic system. Res. Commun. Chem. Pathol. Pharmacol. 6:1052–1062.
Pert, C. B., Aposhian, D., andSnyder, S. H. 1974. Phylogenetic distribution of opiate receptor binding. Brain Res. 75:356–361.
Klee, W. A., andNirenberg, M. 1974. A neuroblastoma x glioma hybrid cell line with opiate receptors. Proc. Natl. Acad. Sci. U.S.A. 71:3474–3477.
Pasternak, G. W., andSnyder, S. H. 1973. Opiate receptor binding: Effects of enzymatic treatment. Mol. Pharmacol. 10:183–193.
Terenius, L. 1979. Characteristics of the “receptor” for narcotic analgesics in synaptic plasma membrane fraction from rat brain. Acta Pharmacol. Toxicol. 33:377–384.
Terenius, L. 1974. Contribution of “receptor” affinity to analgesic potency. J. Pharm. Pharmacol. 26:146–148.
Wilson, R. S., Rogers, M. E., Pert, C. B., andSnyder, S. H., 1975. HomologousN-alkylnorketobemidones. Correlation of receptor binding with analgesic potency. J. Med. Chem. 18:240–242.
Creese, I., andSnyder, S. H. 1975.Receptor binding and pharmacological activity of opiates in the guinea pig intestine. J. Pharmacol. Exp. Ther. 194:205–219.
Clay, G. A., andBrougham, L. R. 1975. Haloperidol binding to an opiate receptor site. Biochem. Pharmacol. 24:1363–1367.
Lowney, L. I., Schulz, K., Lowery, P. J., andGoldstein, A. 1974. Partial purification of an opiate receptor from mouse brain. Science 183:749–753.
Loh, H. H., Cho, T. M., Wu, Y. C., andWay, E. L. 1974. Stereospecific binding of narcotics to brain cerebrosides. Life Sci. 14:2231–2245.
Loh, H. H., Cho, T. M., Wu, Y. C., Harris, R. A., andWay, E. L. 1975. Opiate binding to cerebroside sulfate: A model system for opiate-receptor interaction. Life Sci. 16:1811–1817.
Jaffe, J. H. 1970. Drug addition and drug abuse. Pages 276–313,in Goodman, L. S., andGilman, A. (eds.), The Pharmacological Basis of Therapeutics, 4th ed. MacMillan, New York.
Borison, H. L. 1971. The nervous system. Pages 342–365,in Clouet, D. H. (ed.), Narcotic Drugs Biochemical Pharmacology, Plenum Press, New York.
Kerr, F. W. L., andPozuelo, J. (1971). Suppression of physical dependence and induction of hypersensitivity to morphine by stereotaxic hypothalamic lesions in addicted rats. Proc. Mayo Clinic 46:653–665.
Domino, E. F. 1962. Sites of action of some central nervous system depressants. Annu. Rev. Pharmacol. 2:215–250.
Kuhar, M. J., Pert, C. B., andSnyder, S. H. 1973. Regional distribution of opiate receptor binding in monkey and human brain. Nature 245:447–450.
Mulé, S. J., Casella, G., andClouet, D. H. 1974. Localization of narcotic analgesics in synaptic membranes of rat brain. Res. Commun. Chem. Pathol. Pharmacol. 7:55–77.
Cerletti, C., Manara, L., andMennini, T. 1974. Brain levels of the potent analgesic etorphine in rats and their functional significance. Br. J. Pharmacol. 52:440P-441P.
Höllt, V., Dum, J., Bläsig, J., Schubert, P., andHerz, A. 1975. Comparison ofin vivo andin vitro parameters of opiate receptor binding in naive and tolerant/dependent rodents. Life Sci. 16:1823–1828.
Shen, J. W., andWay, E. L. 1975. Antagonist displacement of brain morphine during precipitated abstinence. Life Sci. 16:1829–1830.
Pert, C. B., andSnyder, S. H. 1975. Identification of opiate receptor binding in intact animals. Life Sci. 16:1623–1634.
Pert, C. B., Kuhar, M. J., andSnyder, S. H. 1975. Autoradiographic localization of the opiate receptor in rat brain. Life Sci. 16:1849–1854.
Simon, E. J. 1975. Opiate receptor binding with3H-etorphine. Neurosci. Res. Program Bull. 13:43–50.
Korf, J., Bunney, B. S., andAghajanian, G. K. 1974. Noradrenergic neurons: Morphine inhibition of spontaneous activity. Eur. J. Pharmacol. 25:165–169.
Schubert, P., Höllt, V., andHerz, A. 1975. Autoradiographic evaluation of the intracerebral distribution of3H-etorphine in the mouse brain. Life Sci. 16:1855–1856.
Pert, C. B., andSynder, S. H. 1974. Opiate receptor binding of agonists and antagonists affected differentially by sodium. Mol. Pharmacol. 10:868–879.
Simon, E. J., Hiller, J. M., Groth, J., andEdelman, I. 1975. Further properties of stereospecific opiate binding sites in rat brain: On the nature of the sodium effect. J. Pharmacol. Exp. Ther. 192:531–537.
Pert, C. B., andSnyder, S. H. 1975. Differential interactions of agonists and antagonists with the opiate receptor. Neurosci. Res. Program Bull. 13:73–79.
Simon, E. J. 1975. Opiate receptors in animal and human brain. Pages 314–322,in Proceedings of the IX Congress of the Collegium Internationale Neuropsychopharmacologium, Paris, July 7–12, 1974, Excerpta Medica, Amsterdam.
Simon, E. J., andGroth, J. 1975. Kinetics of opiate receptor inactivation by sulfhydryl reagents: Evidence for conformational change in presence of sodium ions. Proc. Natl. Acad. Sci. U.S.A. 72:2404–2407.
Pasternak, G. W., Wilson, H. A., andSnyder, S. H. 1975. Differential effects of protein-modifying reagents on receptor binding of opiate agonists and antagonists. Mol. Pharmacol. 11:340–351.
Simon, E. J., Hiller, J. M., Edelman, I., Groth, J., andStahl, K. D. 1975. Opiate receptors and their interactions with agonists and antagonists. Life Sci. 16:1795–1800.
Monod, J., Wyman, J., andChangeux, J. P. 1965. On the nature of allosteric transitions: A plausible model. J. Mol. Biol. 12:88–118.
Changeux, J. P., andRubin, M. M. 1968. Allosteric interactions in aspartate transcarbamylase. III. Interpretation of experimental data in terms of the model of Monod, Wyman, and Changeux. Biochemistry 7:553–561.
Ehrenpreis, S., Greenberg, J., andBelman, S. 1973. Prostaglandins reverse inhibition of electrically-induced contractions of guinea-pig ileum by morphine, indomethacin and acetylsalicilic acid. Nature (London), New Biol. 245:280–282.
Liebeskind, J. C., Mayer, D. J., andAkil, H. 1974. Central mechanisms of pain inhibition: Studies of analgesia from focal brain stimulation. Pages 261–268,in Bonica, J. J. (ed.), Advances in Neurology, Vol 4, International Symposium on Pain, Raven Press New York.
Mayer, D. J., andLiebeskind, J. C. 1974. Pain reduction by focal electrical stimulation of the brain: An anatomical and behavioral analysis. Brain Res. 68:73–93.
Mayer, D. J., andHayes, R. 1975. Stimulation-produced analgesia: Development of tolerance and cross-tolerance to morphine. Science 188:941–943.
Hughes, J. 1975. Search for the endogenous ligand of the opiate receptor. Neurosci. Res. Program Bull. 13:55–58.
Hughes, J. 1975. Isolation of an endogenous compound from the brain with properties similar to morphine. Brain Res. 88:295–308.
Terenius, L., andWahlström, A. 1974. Inhibitor(s) of narcotic receptor binding in brain extracts and cerebrospinal fluid. Acta Pharmacol. Toxicol. 35(Suppl. 1):55.
Terenius, L., andWahlström, A. 1975. Search for an endogenous ligand for the opiate receptor. Acta Physiol. Scand. 94:74–81.
Pasternak, G. W., Goodman, R., andSnyder, S. H. 1975. An endogenous morphine-like factor in mammalian brain. Life Sci. 16:1765–1769.
Hughes, J., Smith, T. W., Kosterlitz, H. W., Fothergill, L. A., Morgan, B. A., andMorris, H. R. 1975. Identification of two related pentapeptides from the brain with potent opiate agonist activity. Nature 258:577–579.
Terenius, L., andWahlström, A. 1975. Morphine-like ligand for opiate receptors in human CSF. Life Sci. 16:1759–1764.
Teschemacher, H., Opheim, K. E., Cox, B. M., andGoldstein, A. 1975. A peptide-like substance from pituitary that acis like morphine. 1. Isolation. Life Sci. 16:1771–1776.
Terenius, L. 1975. Effect of peptides and amino acids on dihyromorphine binding to the opiate receptor. J. Pharm. Pharmacol. 27:450–452.
Cox, B. M., Opheim, K. E., Teschemacher, H., andGoldstein, A. 1975. A peptide-like substance from pituitary that acts like morphine. 2. Purification and properties. Life Sci. 16:1777–1782
Eylar, E. H. 1972. The structure and immunologic properties of basic proteins of myelin. Ann. N.Y. Acad. Sci. 195:481–491.
Simon, E. J., Hiller, J. M., andEdelman, I. 1975. Solubilization of a stereospecific opiate-macromolecular complex from rat brain. Science 190:389–390.
Simon, E. J., Dole, W. P., andHiller, J. M. 1972. Coupling of a new, active morphine derivative to Sepharose for affinity chromatography. Proc. Natl. Acad. Sci. U.S.A. 69:1835–1837.
Simon, E. J., 1974. Morphine and related drugs. Pages 619–623,in Jacoby, W. B., andWilchek, M. (eds.), Methods in Enzymology, Vol. 34B, Affinity Techniques, Academic Press, New York.
Collier, H. O. J., andRoy, A. C. 1974. Morphine-like drugs inhibit the stimulation by E prostaglandins of cyclic AMP formation by rat brain homogenates. Nature 248:24–27.
Collier, H. O. J., andRoy, A. C. 1974. Hypothesis: Inhibition of E-prostaglandinsensitive adenyl cyclase as the mechanism of morphine analgesia. Prostaglandins 7:361–376.
Collier, H. O. J., Francis, D. L., Henderson, G., andScheider, S. 1974. Quasi morphine-abstinence syndrome. Nature 249:471–473.
Sharma, S. K., Nirenberg, M., andKlee, W. A. 1975. Morphine receptors as regulators of adenylate cyclase activity. Proc. Natl. Acad. Sci. U.S.A. 72:590–594.
Traber, J., Fischer, K., Latzin, S., andHamprecht, B. 1974. Morphine antagonizes the action of prostaglandin in neuroblastoma cells but not of prostaglandin and noradrenaline in glioma and glioma x fibroblast hybrid cells. FEBS Lett. 49:260–263.
Collier, H. O. J. 1965. A general theory of the genesis of drug dependence by induction of receptors. Nature 205:181–183.
Collier, H. O. J. 1966. Tolerance, physical dependence and receptors. Adv. Drug Res. 3:171–188.
Klee, W. A., andStreaty, R. A. 1974. Narcotic receptor sites in morphinedependent rats. Nature 248:61–63.
Pert, C. B., Pasternak, G., andSnyder, S. H. 1973. Opiate agonists and antagonists discriminated by receptor binding in brain. Science 182:1359–1361.
Way, E. L., Loh, H. H., andShen, F. H. 1969. Simultaneous quantitative assessment of morphine tolerance and physical dependence. J. Pharmacol. Exp. Ther. 167:1–8.
Sharma, S. K., Klee, W. A., andNirenberg, M. 1975. Dual regulation of adenylate cyclase accounts for narcotic dependence and tolerance. Proc. Natl. Acad. Sci. U.S.A. 72:3092–3096.
Traber, J., Gullis, R., andHamprecht, B. 1975. Influence of opiates on the levels of adenosine 3′:5′-cyclic monophosphate in neuroblastoma x glioma hybrid cells. Life Sci. 16:1863–1868.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Simon, E.J. The opiate receptors. Neurochem Res 1, 3–28 (1976). https://doi.org/10.1007/BF00965627
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00965627